Search results for "Osteosarcoma"

showing 10 items of 103 documents

A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models.

2010

Osteosarcomas (OS) are aggressive neoplasms with a wide range of morphologic patterns.OS cases (primary and xenotransplanted) with paraffin blocks available were collected and included in tissue microarrays (TMAs). A morphologic evaluation including the different passages in mice was carried out according to the new WHO criteria. In addition, TMAs were analyzed with a wide panel of immunohistochemical (IHC) markers (osteonectin, osteocalcin,cytokeratin, S100, Sox-9, Ki-67, Bcl-2, p53, p16, survivin, CD99, and caveolin-1).A total of 61 cases were collected. The distribution of the cases according to the histopathologic pattern was: 38 osteogenic OS, 8 primary chondrogenic OS, 2 primary telan…

MalePathologymedicine.medical_specialtyHistologyCD99OsteocalcinTransplantation HeterologousMice NudePathology and Forensic MedicineCytokeratinMiceSurvivinmedicineBiomarkers TumorAnimalsHumansOsteonectinOsteosarcomaTissue microarraybiologybusiness.industrymedicine.diseaseMicroarray AnalysisImmunohistochemistryTransplantationMedical Laboratory TechnologyDisease Models Animalbiology.proteinCancer researchDisease ProgressionImmunohistochemistryOsteosarcomaFeasibility StudiesOsteonectinbusinessApplied immunohistochemistrymolecular morphology : AIMM
researchProduct

MiR-29b-1 expression impaired Cancer Stem-Like properties of human osteosarcoma 3AB-OS cells in vitro.

2013

Osteosarcoma (OS) is the most common type of bone cancer, with a peak incidence in the early childhood. Emerging evidence suggests that treatments targeting cancer stem cells (CSCs) within a tumor can halt cancer and improve patient survival. Although microRNAs are frequently dysregulated in human cancers, if they influence OS malignancy and whether or not targeting CSC-associated microRNAs inhibit OS progression remain unclear. Recently (1), we described a predictive network for two downregulated miRNA family (let-7/98 and miR-29a,b,c) and their upregulated anticorrelated mRNAs. Here, we investigated in vitro the role of miR-29b-1 in regulating cell proliferation, clonogenic growth and che…

MiR-29b-1 3AB-OS CSCs Osteosarcoma
researchProduct

MicroRNA-29b-1 is involved in self-renewal and fate decisions of human osteosarcoma 3AB-OS cancer stem cells

2014

Emerging evidence suggests that treatments targeting cancer stem cells (CSCs) within a tumor can halt cancer and improve patient survival. Moreover, identification of CSC-related MicroRNAs (miRNAs) would provide information for a better understanding of CSCs. miR-29 family is a class of miRNAs aberrantly expressed in multiple cancers. They are frequently down-regulated in osteosarcoma (OS), the most common form of childhood cancer with a potent metastasizing potential. 3AB-OS CSC, a human pluripotent CSC line by us produced from the human osteosarcoma MG63 cells (1) is a useful model to study CSC origin and roles (2). Previously, we have shown that in 3AB-OS CSCs miR-29b is potently down-re…

MicroRNA-29b-1 self-renewal human osteosarcoma 3AB-OS cancer stem cells
researchProduct

IN CELLULE DI OSTEOSARCOMA UMANO MG-63, IL TRATTAMENTO CON 3-AMINOBENZAMIDE FAVORISCE L’ESPANSIONE DI UNA POPOLAZIONE CELLULARE “STEM-LIKE”

2009

OSTEOSARCOMA UMANO cellule MG-63 3-AMINOBENZAMIDE cellule staminali cancerose
researchProduct

STUDY ON P53 GAIN OF FUNCTION IN 3AB-OS CANCER STEM CELLS

OSTEOSARCOMAMUTANT P53; STEMNESS; CANCER; OSTEOSARCOMA; CANCER STEM CELLS.STEMNESSCANCER STEM CELLS.CANCERMUTANT P53
researchProduct

Circulating leukocyte telomere length and oxidative stress: A new target for statin therapy

2011

International audience; Objectives: We investigated the relationship between prior statin therapy and leukocyte telomere length (LTL), as well as their interaction with potential new biomarkers of oxidative deoxyribonucleic acid (DNA) lesions and reactive oxygen species-induced inflammation.Methods and results: From patients admitted for an acute myocardial infarction, LTL was assessed by quantitative polymerase chain reaction (Q-PCR), and leukocyte Finkel-Biskis-Jinkins osteosarcoma (FOS) and 8-oxoguanine DNA glycosylase (OGG1) messenger ribonucleic acid (mRNA) levels were measured by retrotranscription Q-PCR. Patients under prior chronic statin therapy were compared with patients without …

OncologyMaleMyocardial Infarction030204 cardiovascular system & hematologymedicine.disease_causeDNA Glycosylases0302 clinical medicineRisk FactorsLeukocytesMyocardial infarctionComputingMilieux_MISCELLANEOUSAged 80 and over0303 health sciencesReverse Transcriptase Polymerase Chain ReactionConfoundingMiddle AgedTelomere3. Good health[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemReal-time polymerase chain reactionOsteosarcomaFemalemedicine.symptomCardiology and Cardiovascular MedicineProto-Oncogene Proteins c-fosGenetic Markersmedicine.medical_specialtyStatinmedicine.drug_classInflammationReal-Time Polymerase Chain ReactionRisk Assessment03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicinemedicineHumansRNA MessengerPropensity Score030304 developmental biologyAgedDyslipidemiasChi-Square Distributionbusiness.industrystatinoxidative stress 2medicine.diseaseLeukocyte telomere lengthSurgeryOxidative StressLogistic ModelsinflammationLinear ModelsHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessChi-squared distributionOxidative stress
researchProduct

49P Targeting IGF1R in osteosarcoma

2020

Oncologybusiness.industryCancer researchMedicineOsteosarcomaHematologybusinessmedicine.diseaseInsulin-like growth factor 1 receptorAnnals of Oncology
researchProduct

Progress of Phototherapy Applications in the Treatment of Bone Cancer

2021

Bone cancer including primary bone cancer and metastatic bone cancer, remains a challenge claiming millions of lives and affecting the life quality of survivors. Conventional treatments of bone cancer include wide surgical resection, radiotherapy, and chemotherapy. However, some bone cancer cells may remain or recur in the local area after resection, some are highly resistant to chemotherapy, and some are insensitive to radiotherapy. Phototherapy (PT) including photodynamic therapy (PDT) and photothermal therapy (PTT), is a clinically approved, minimally invasive, and highly selective treatment, and has been widely reported for cancer therapy. Under the irradiation of light of a specific wa…

Oncologymedicine.medical_specialtyQH301-705.5Photothermal Therapymedicine.medical_treatmentCancer therapyBone NeoplasmsPhotodynamic therapyReviewCatalysisInorganic ChemistryInternal medicineHumansMedicineBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologySpectroscopyOsteosarcomaChemotherapyPhotosensitizing Agentsbusiness.industryBone cancerOrganic ChemistryCancerbone cancerGeneral MedicinePhototherapyPhotothermal therapymedicine.diseaseComputer Science ApplicationsRadiation therapyChemistryPrimary bonephotodynamic therapyPhotochemotherapyNanoparticlesGoldtumor therapyNeoplasm Recurrence LocalReactive Oxygen SpeciesbusinessInternational Journal of Molecular Sciences
researchProduct

Maxillofacial reconstruction in a pediatric patient with Osteosarcoma

2011

Osteosarcoma is a bone tumor that consists of malignant cells that produce immature bone. Is a bone tumor that develops during periods of rapid growth in adolescents and young adults. It is the most common type of bone cancer in children and adolescents. The diagnosis and treatment of patients with osteosarcoma requires a multidisciplinary team approach. Resection of maxillary tumours remains a surgical challenge due to the possible aesthetic and functional secuelae. We present herein the case of a 15 year-old female with an osteoblastic osteosarcoma of the left maxilla. It was treated with eight cycles of neoadjuvant chemotherapy, followed by a total left maxillectomy. Resection was perfor…

Osteoblastic osteosarcomamedicine.medical_specialtyChemotherapybusiness.industryBone cancermedicine.medical_treatmentOdontologíamedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryPediatric patientLeft maxillaUNESCO::CIENCIAS MÉDICASmedicineOsteosarcomaPalatal obturatorbusinessGeneral DentistryImmature Bone
researchProduct

Differentiative pathway activated by 3-aminobenzamide in human osteosarcoma MG-63 cells involves FAK and PAK activities.

2006

PARP inhibitorosteosarcomafocal adhesions
researchProduct